Detection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smear-Biopsy
HPV-BIOFRO
1 other identifier
interventional
80
1 country
2
Brief Summary
Multicentre prospective study of concordance between two tissue sampling modes (smear / biopsy), which applies the same diagnostic method (PCR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2012
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 2, 2015
CompletedFirst Posted
Study publicly available on registry
January 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedAugust 22, 2017
August 1, 2017
5.2 years
November 2, 2015
August 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the correlation between the two sampling methods
the correlation between the two sampling methods (smear and biopsy), defined by the probability of positive correlation and the negative concordance probability.
1 month
Secondary Outcomes (2)
rate of concordance for the detection of HPV between biopsy and smear
1 month
the overall agreement
1 month
Study Arms (1)
patient with suspected lesions of the tonsillar region
OTHERpatients will have a tonsil biopsy and a smear
Interventions
Biopsies were obtained during endoscopy of Aero-Digestive Tract Superior under general anesthesia.
The smears are made in consultation a fortnight before performing endoscopic examination. They are carried out after a local anesthetic spray in order to optimize the number of cells collected.
Eligibility Criteria
You may qualify if:
- Presents a suspicious lesion of the amygdala region
- Have a biopsy of the oropharynx planned in the operating room.
You may not qualify if:
- Pregnant Patient.
- Against anesthetic or surgical indication for endoscopy of the upper aerodigestive tract.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU Toulouse
Toulouse, France
Institut Claudius Regaud
Toulouse, France
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin VAIREL, Doctor
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2015
First Posted
January 15, 2016
Study Start
March 1, 2012
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
August 22, 2017
Record last verified: 2017-08